查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1266534

全球基因合成市場：按方法、按最終用戶：機會分析和行業預測，2021-2031 年

Gene Synthesis Market By Method, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格

預計2021年全球基因合成市場規模為11.1億美元，2031年銷售額為59.79億美元，複合年增長率為18.4%。

基因合成是一種創造或生產人工基因的科學方法。 基因合成是指使用旨在從核甘酸組裝和構建基因的各種方法來創建基因的過程。 核甘酸是製造核酸過程中必不可少的組成部分。

實際上，RNA 和 DNA 是由很長的核甘酸序列組成的。 這些化學物質由附著在含有磷酸鹽和氮的鹼基上的糖分子組成。 基因合成技術使科學家和研究人員能夠精確指定和定制所需的序列。

老年人口的增加、慢性病發病率的上升、具有成本效益的治療以及對新型疫苗的需求增加是預計將推動基因合成市場增長的一些主要因素。 隨著傳染病在世界範圍內蔓延，對有效治療方法和疫苗的需求增加，促使研究人員和科學家加快研究工作，尋找治療癌症和腫瘤等疾病的有效方法。我不得不創造它。 某些疾病可以用化學藥物和生物療法（如基因療法）有效治療。 基因組學的應用加強了地方病和傳染病的治療。 我們還可以更好地了解新的耐藥性並確定疫苗和新藥的潛在目標。 基因療法在感染性疾病的治療中引起了許多研究者的興趣，因為它可以通過重組DNA技術、DNA&RNA核□、單鏈抗體等進行治療。

隨著基因治療技術的快速發展，患者基因插入和基因治療需要更先進的技術和經驗豐富的人力資源。 在整個預測期內，大多數醫療保健專業人員無法進行治療可能會對基因合成市場產生負面影響。

政府加大對涉及新基因合成的研究的支持，提高療效，以及研究人員、科學家、製藥和生物技術公司加大研發力度，預計將推動未來的市場增長。 此外，確保每個人都能從新開發技術的治療中受益的報銷政策有望在未來幾年加速市場增長。 這促進了基因合成市場的增長。

COVID-19 大流行正以積極和消極的方式影響基因合成行業。 在大流行初期，2019冠狀病毒病（COVID-19）對材料供應、生產和物流運營構成了重大挑戰，對細胞和基因治療（CGT）業務產生了重大影響。 當 COVID-19 疫情開始時，全球大多數公司和研究機構都關閉了，減少了基因合成儀的市場需求和實驗室使用。

COVID-19 疫情為基因合成業務提供了巨大的增長潛力。 基因合成是一個具有未知潛力的主題，它支持市場在創收方面的增長。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 頂級影響因子
    • 頂級投資基金
  • 波特的五力分析
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • 分析 COVID-19 對市場的影響
  • 關鍵法規分析
  • 市場份額分析
  • 專利情況
  • 監管準則
  • 價值鏈分析

第 4 章基因合成市場：按方法分類

  • 概覽
    • 市場規模和預測
  • 固相合成
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 通過 PCR 方法合成□
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 通過 CHIP 合成 DNA
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析

第 5 章基因合成市場：最終用戶

  • 概覽
    • 市場規模和預測
  • 學術和研究機構，
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 生物技術和製藥公司，
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 診斷實驗室
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析

第 6 章基因合成市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機遇
    • 市場規模/預測：按方法
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
  • 歐洲
    • 主要趨勢和機遇
    • 市場規模/預測：按方法
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
  • 亞太地區
    • 主要趨勢和機遇
    • 市場規模/預測：按方法
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
  • 拉美
    • 主要趨勢和機遇
    • 市場規模/預測：按方法
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 阿聯酋
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類
      • LAMEA 的其餘部分
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按方法
      • 市場規模和預測：按最終用戶分類

第七章競爭格局

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 定位頂級公司，2021 年

第八章公司簡介

  • Genscript Technology
  • Brooks Automation, Inc.
  • Boster Biological Technology
  • Twist Bioscience
  • Codex DNA
  • Biomatik
  • promab biotechnologies, inc.
  • Thermo Fisher Scientific, Inc.
  • Integrated DNA Technologies, Inc.
  • OriGene Technologies, Inc.
Product Code: A39015

The global gene synthesis market size was $1,110 million in 2021 and is predicted to grow with a CAGR of 18.4%, by generating a revenue of $5,979 million by 2031.

Gene synthesis is the scientific method for generating or producing artificial genes. Gene synthesis refers to the process by which genes are created using various ways aimed at assembling and constructing genes from nucleotides. Nucleotide is an essential building block in the process of creating nucleic acid. 

In reality, RNA and DNA are made up of lengthy sequences of nucleotides. These chemicals are made up of sugar molecules coupled to a phosphate and a nitrogen-containing base. The gene synthesis technique enables scientists and researchers to precisely specify and tailor the desired sequence. 

The increase in the geriatric population, rise in the incidence of chronic illnesses, cost-effective treatment, and increase in demand for novel vaccines are some of the primary factors anticipated to drive the gene synthesis market growth. Because of the rising prevalence of infectious diseases around the world, the demand for effective treatments and vaccines has increased, prompting researchers and scientists to accelerate their research efforts and produce effective treatment options for diseases such as cancer and tumors. Certain illnesses can be effectively treated with chemical drugs and biological treatments, such as gene therapy. The application of genomics has enhanced the treatment of endemic and infectious diseases. It also allows us to better understand new drug resistance and identify possible targets for vaccines and new medicines. Gene therapy has piqued the interest of many researchers for the treatment of infectious diseases since it can be treated with recombinant DNA technology, DNA & RNA ribozyme, and single chain antibodies.  

The rapid evolution of the technology involved in gene therapy necessitates increased skill work and experienced individuals for the insertion of genes or the execution of gene therapy procedures in patients. Most healthcare professionals' inability to carry out the therapy may have a negative impact on the gene synthesis market throughout the forecast period. 

Increase in government support for the research involving synthesis of new genes,  rise in therapy efficiency, and growth in research and development by the researchers, scientists, and pharmaceutical & biotechnological companies is expected to drive the market growth in the future. In addition, the market growth is expected to boost in the coming years owing to reimbursement policies so that every individual can benefit from the treatment of new technologies developed. This contributes to the rise in the gene synthesis market. 

The COVID-19 pandemic has had an impact on the gene synthesis industry, both positively and negatively. During the initial phase of the pandemic, the coronavirus 2019 (COVID-19), which has caused significant challenges in the supply of materials, production, and logistical operations, significantly impacted the cell and gene therapy (CGT) business. When the COVID-19 pandemic began, most businesses and research initiatives around the world suspended operations, reducing market demand for gene synthesizers and their use in laboratories. 

The spread of the COVID-19 pandemic has aided the gene synthesis business by creating enormous growth possibilities. The topic of gene synthesis is being investigated for undiscovered potential, which is supporting the growth of the market in terms of revenue creation. 

The key players profiled in this report include: Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc. 

The gene synthesis market is segmented on the basis of method, end user, and region. As per method, the market has been divided into solid phase synthesis, PCR-based enzyme synthesis, and CHIP-based DNA synthesis. By end user, the market has been classified into academic and research institutes, biotech and pharmaceutical companies, diagnostic laboratories, and other. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the gene synthesis market analysis from 2021 to 2031 to identify the prevailing gene synthesis market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the gene synthesis market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global gene synthesis market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Method

  • Solid Phase Synthesis
  • PCR Based Enzyme Synthesis
  • CHIP Based DNA Synthesis

By End User

  • Biotech and Pharmaceutical Companies,
  • Diagnostic Laboratories
  • Academic and Research Institutes,
  • Other

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Brooks Automation, Inc.
  • Boster Biological Technology
  • Twist Bioscience
  • Codex DNA
  • Biomatik
  • promab biotechnologies, inc.
  • Thermo Fisher Scientific, Inc.
  • Genscript Technology
  • Integrated DNA Technologies, Inc.
  • OriGene Technologies, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. COVID-19 Impact Analysis on the market
  • 3.6. Key Regulation Analysis
  • 3.7. Market Share Analysis
  • 3.8. Patent Landscape
  • 3.9. Regulatory Guidelines
  • 3.10. Value Chain Analysis

CHAPTER 4: GENE SYNTHESIS MARKET, BY METHOD

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Solid Phase Synthesis
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. PCR Based Enzyme Synthesis
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. CHIP Based DNA Synthesis
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: GENE SYNTHESIS MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Academic and Research Institutes,
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Biotech and Pharmaceutical Companies,
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Other
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: GENE SYNTHESIS MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Method
    • 6.2.3. Market size and forecast, by End User
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Method
      • 6.2.4.1.3. Market size and forecast, by End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Method
      • 6.2.4.2.3. Market size and forecast, by End User
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Method
      • 6.2.4.3.3. Market size and forecast, by End User
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Method
    • 6.3.3. Market size and forecast, by End User
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. UK
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Method
      • 6.3.4.1.3. Market size and forecast, by End User
      • 6.3.4.2. Germany
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Method
      • 6.3.4.2.3. Market size and forecast, by End User
      • 6.3.4.3. France
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Method
      • 6.3.4.3.3. Market size and forecast, by End User
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Method
      • 6.3.4.4.3. Market size and forecast, by End User
      • 6.3.4.5. Italy
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Method
      • 6.3.4.5.3. Market size and forecast, by End User
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Method
      • 6.3.4.6.3. Market size and forecast, by End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Method
    • 6.4.3. Market size and forecast, by End User
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Method
      • 6.4.4.1.3. Market size and forecast, by End User
      • 6.4.4.2. India
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Method
      • 6.4.4.2.3. Market size and forecast, by End User
      • 6.4.4.3. Japan
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Method
      • 6.4.4.3.3. Market size and forecast, by End User
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Method
      • 6.4.4.4.3. Market size and forecast, by End User
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Method
      • 6.4.4.5.3. Market size and forecast, by End User
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Key market trends, growth factors and opportunities
      • 6.4.4.6.2. Market size and forecast, by Method
      • 6.4.4.6.3. Market size and forecast, by End User
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Method
    • 6.5.3. Market size and forecast, by End User
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Method
      • 6.5.4.1.3. Market size and forecast, by End User
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Method
      • 6.5.4.2.3. Market size and forecast, by End User
      • 6.5.4.3. UAE
      • 6.5.4.3.1. Key market trends, growth factors and opportunities
      • 6.5.4.3.2. Market size and forecast, by Method
      • 6.5.4.3.3. Market size and forecast, by End User
      • 6.5.4.4. South Africa
      • 6.5.4.4.1. Key market trends, growth factors and opportunities
      • 6.5.4.4.2. Market size and forecast, by Method
      • 6.5.4.4.3. Market size and forecast, by End User
      • 6.5.4.5. Rest of LAMEA
      • 6.5.4.5.1. Key market trends, growth factors and opportunities
      • 6.5.4.5.2. Market size and forecast, by Method
      • 6.5.4.5.3. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

  • 8.1. Genscript Technology
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
  • 8.2. Brooks Automation, Inc.
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
  • 8.3. Boster Biological Technology
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
  • 8.4. Twist Bioscience
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
  • 8.5. Codex DNA
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
  • 8.6. Biomatik
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
  • 8.7. promab biotechnologies, inc.
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
  • 8.8. Thermo Fisher Scientific, Inc.
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
  • 8.9. Integrated DNA Technologies, Inc.
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
  • 8.10. OriGene Technologies, Inc.
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot

LIST OF TABLES

  • TABLE 01. GLOBAL GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 02. GENE SYNTHESIS MARKET FOR SOLID PHASE SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 03. GENE SYNTHESIS MARKET FOR PCR BASED ENZYME SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 04. GENE SYNTHESIS MARKET FOR CHIP BASED DNA SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 05. GLOBAL GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 06. GENE SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 07. GENE SYNTHESIS MARKET FOR BIOTECH AND PHARMACEUTICAL COMPANIES,, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 08. GENE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 09. GENE SYNTHESIS MARKET FOR OTHER, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 10. GENE SYNTHESIS MARKET, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 11. NORTH AMERICA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 12. NORTH AMERICA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 13. NORTH AMERICA GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 14. U.S. GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 15. U.S. GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 16. CANADA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 17. CANADA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 18. MEXICO GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 19. MEXICO GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 20. EUROPE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 21. EUROPE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 22. EUROPE GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 23. UK GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 24. UK GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 25. GERMANY GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 26. GERMANY GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 27. FRANCE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 28. FRANCE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 29. SPAIN GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 30. SPAIN GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 31. ITALY GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 32. ITALY GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 33. REST OF EUROPE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 34. REST OF EUROPE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 35. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 36. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 37. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 38. CHINA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 39. CHINA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 40. INDIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 41. INDIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 42. JAPAN GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 43. JAPAN GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 44. SOUTH KOREA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 45. SOUTH KOREA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 46. AUSTRALIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 47. AUSTRALIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 48. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 49. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 50. LAMEA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 51. LAMEA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 52. LAMEA GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 53. BRAZIL GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 54. BRAZIL GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 55. SAUDI ARABIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 56. SAUDI ARABIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 57. UAE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 58. UAE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 59. SOUTH AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 60. SOUTH AFRICA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 61. REST OF LAMEA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 62. REST OF LAMEA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 63. GENSCRIPT TECHNOLOGY: KEY EXECUTIVES
  • TABLE 64. GENSCRIPT TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 65. BROOKS AUTOMATION, INC.: KEY EXECUTIVES
  • TABLE 66. BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT
  • TABLE 67. BOSTER BIOLOGICAL TECHNOLOGY: KEY EXECUTIVES
  • TABLE 68. BOSTER BIOLOGICAL TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 69. TWIST BIOSCIENCE: KEY EXECUTIVES
  • TABLE 70. TWIST BIOSCIENCE: COMPANY SNAPSHOT
  • TABLE 71. CODEX DNA: KEY EXECUTIVES
  • TABLE 72. CODEX DNA: COMPANY SNAPSHOT
  • TABLE 73. BIOMATIK: KEY EXECUTIVES
  • TABLE 74. BIOMATIK: COMPANY SNAPSHOT
  • TABLE 75. PROMAB BIOTECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 76. PROMAB BIOTECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 77. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 78. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 79. INTEGRATED DNA TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 80. INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 81. ORIGENE TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 82. ORIGENE TECHNOLOGIES, INC.: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. GENE SYNTHESIS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF GENE SYNTHESIS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN GENE SYNTHESIS MARKET (2022-2031)
  • FIGURE 04. PORTER FIVE-1
  • FIGURE 05. PORTER FIVE-2
  • FIGURE 06. PORTER FIVE-3
  • FIGURE 07. PORTER FIVE-4
  • FIGURE 08. PORTER FIVE-5
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALGENE SYNTHESIS MARKET
  • FIGURE 10. IMPACT OF KEY REGULATION: GENE SYNTHESIS MARKET
  • FIGURE 11. MARKET SHARE ANALYSIS: GENE SYNTHESIS MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. REGULATORY GUIDELINES: GENE SYNTHESIS MARKET
  • FIGURE 15. VALUE CHAIN ANALYSIS: GENE SYNTHESIS MARKET
  • FIGURE 16. GENE SYNTHESIS MARKET, BY METHOD, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR SOLID PHASE SYNTHESIS, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR PCR BASED ENZYME SYNTHESIS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR CHIP BASED DNA SYNTHESIS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. GENE SYNTHESIS MARKET, BY END USER, 2021(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR BIOTECH AND PHARMACEUTICAL COMPANIES,, BY COUNTRY 2021-2031(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY 2021-2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR OTHER, BY COUNTRY 2021-2031(%)
  • FIGURE 25. GENE SYNTHESIS MARKET BY REGION, 2021
  • FIGURE 26. U.S. GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 27. CANADA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 28. MEXICO GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 29. UK GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 30. GERMANY GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 31. FRANCE GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 32. SPAIN GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 33. ITALY GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 34. REST OF EUROPE GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 35. CHINA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 36. INDIA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 37. JAPAN GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 38. SOUTH KOREA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 39. AUSTRALIA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 40. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 41. BRAZIL GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 42. SAUDI ARABIA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 43. UAE GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 44. SOUTH AFRICA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 45. REST OF LAMEA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50. COMPETITIVE DASHBOARD
  • FIGURE 51. COMPETITIVE HEATMAP: GENE SYNTHESIS MARKET
  • FIGURE 52. TOP PLAYER POSITIONING, 2021